Tumor Suppressor Genes: Definition, Types, Mechanisms, Two-Hit Hypothesis, Functions, and Role in Cancer

Table of Contents

• Introduction to Tumor Suppressor Genes
• What are Tumor Suppressor Genes? 
• Discovery of Tumor Suppressor Genes
• Two-Hit Hypothesis of Tumor Suppressor Genes
• Types of Tumor Suppressor Genes
• Mechanisms of Tumor Suppressor Genes
• References

Introduction to Tumor Suppressor Genes

• Tumor suppressor genes are specialized genes that help prevent the uncontrolled growth and division of cells.
• Under normal conditions, cells possess natural defense mechanisms that regulate cell proliferation and protect against cancer development.
• These genes play a critical role in maintaining normal cell growth, repairing DNA damage, controlling the cell cycle, and eliminating damaged cells when necessary.
• When tumor suppressor genes become mutated, inactivated, or disrupted, these protective mechanisms fail.
• The loss of tumor suppressor gene function allows abnormal cells to proliferate uncontrollably, significantly increasing the risk of cancer development.

What are Tumor Suppressor Genes? 

• Tumor suppressor genes are genes that encode proteins responsible for regulating essential cellular processes that inhibit cell proliferation, maintain genomic stability, and promote programmed cell death (apoptosis) when necessary.
• These genes act as the cell's natural defense system by preventing the formation and growth of cancerous cells.
• Tumor suppressor proteins help control the cell cycle, repair damaged DNA, initiate apoptosis in irreparably damaged cells, and prevent the accumulation of harmful mutations.
• Under normal conditions, they ensure that cells divide only when required and maintain normal tissue homeostasis.
• Loss, mutation, deletion, or inactivation of tumor suppressor genes impairs these protective mechanisms.
• As a result, abnormal cells can proliferate uncontrollably, accumulate additional genetic mutations, and eventually develop into cancer.
• Unlike oncogenes, which promote excessive cell growth when activated, tumor suppressor genes contribute to cancer development primarily when their function is lost or disabled.

Discovery of Tumor Suppressor Genes

• The concept of tumor suppressor genes emerged from studies investigating the behavior of normal and cancer cells in culture.
• In 1960, Georges Barski and colleagues discovered that cells from different lineages could occasionally fuse to form hybrid cells when grown together.
• This cell fusion could be artificially induced using inactivated Sendai virus, which promotes the fusion of cell membranes.
• When cancer cells were fused with normal cells, the resulting hybrid cells lost their cancerous characteristics and exhibited normal, regulated cell growth instead of uncontrolled proliferation.
• However, after prolonged culture, some hybrid cells reverted to a malignant phenotype, regaining the uncontrolled growth behavior of the original cancer cells.
• Researchers observed that this reversion was associated with the loss of specific chromosomes, providing strong evidence that these chromosomes contained genes capable of suppressing tumor formation.
• These findings led to the identification of tumor suppressor genes, which normally prevent abnormal cell growth and cancer development.
• The Retinoblastoma (RB1) gene was the first tumor suppressor gene to be identified.
• Mutations or inactivation of the RB1 gene greatly increase the risk of developing Retinoblastoma, with affected individuals having an approximately 10,000-fold higher risk than the general population.
• Much of the early understanding of tumor suppressor gene function was derived from research on the RB1 gene, making it a landmark discovery in cancer genetics.

Two-Hit Hypothesis of Tumor Suppressor Genes

• The two-hit hypothesis explains how mutations in tumor suppressor genes contribute to cancer development. It was proposed by Alfred Knudson in 1971 while studying Retinoblastoma.
• Tumor suppressor gene mutations can be:
• Germline mutations – inherited from a parent and present in all cells from birth.
• Somatic mutations – acquired during a person's lifetime in specific cells due to DNA replication errors or environmental factors.
• Tumor suppressor genes generally behave as recessive genes at the cellular level, meaning both copies (alleles) of the gene must be inactivated before their tumor-suppressing function is lost.
• Individuals with only one mutated allele usually do not develop cancer immediately because the remaining normal allele continues to perform its protective function. However, they have a significantly higher risk of cancer if the second allele is later inactivated.
• This requirement for the loss of both functional gene copies is known as the two-hit hypothesis, where the first "hit" is the initial mutation and the second "hit" results in complete loss of gene function.
• A classic example is Li-Fraumeni syndrome, in which individuals inherit one defective copy of the TP53 gene. These individuals have an increased lifetime risk of developing cancer when the second normal TP53 allele acquires a somatic mutation.
• Knudson developed this hypothesis through his studies of retinoblastoma, a rare childhood eye cancer that originates from immature retinoblasts in the retina. Instead of differentiating into mature retinal photoreceptor cells, these cells continue dividing uncontrollably and form a tumor.
• During normal embryonic development, retinal precursor cells stop dividing at the appropriate stage and differentiate into specialized photoreceptor cells, maintaining normal retinal function.
• Approximately 40% of retinoblastoma cases are hereditary, resulting from an inherited germline mutation in the RB1 gene.
• The RB1 gene is essential for regulating the cell cycle, preventing excessive cell proliferation, and promoting apoptosis of damaged cells.
• Retinoblastoma develops only after both RB1 alleles become inactivated. In hereditary cases, one mutated allele is inherited, and only a second somatic mutation is required for tumor formation. In non-hereditary (sporadic) cases, both mutations occur somatically within the same retinal cell during the individual's lifetime.

Types of Tumor Suppressor Genes

Tumor suppressor genes are essential for maintaining normal cellular functions, regulating cell growth, preserving genomic stability, and preventing uncontrolled cell proliferation.

Based on their biological functions, tumor suppressor genes are classified into five major types:

• Cell cycle regulatory genes: Control the progression of cells through different phases of the cell cycle, ensuring that cell division occurs only when appropriate. 
• Examples: pRB (RB1) and p16 (CDKN2A).
• Genes involved in anti-proliferative signaling pathways: Encode proteins that transmit signals in response to external or internal stimuli to inhibit excessive cell growth and division. 
• Examples: Transforming Growth Factor-beta (TGF-β) pathway genes and Adenomatous Polyposis Coli (APC).
• Checkpoint control genes: Encode proteins that monitor DNA integrity during the cell cycle and temporarily halt cell cycle progression if DNA damage or replication errors are detected, allowing time for repair. 
• Examples: BRCA1 and BRCA2.
• Apoptosis-regulating genes: Encode proteins that initiate programmed cell death (apoptosis) when cellular damage is severe or irreparable, preventing the survival of potentially cancerous cells. 
• Example: TP53 (p53).
• DNA repair genes: Encode proteins responsible for detecting and repairing DNA damage, thereby maintaining genomic stability and reducing mutation accumulation. 
• Example: MSH2 (DNA mismatch repair protein 2).

Mutations, deletions, or inactivation of these tumor suppressor genes impair their protective functions, allowing abnormal cells to evade growth control, accumulate genetic mutations, and increase the risk of cancer development.

Mechanisms of Tumor Suppressor Genes

Over several decades of cancer research, numerous tumor suppressor genes have been identified, although many remain undiscovered. Each tumor suppressor gene functions through distinct mechanisms depending on its specific cellular role and molecular complexity.

Some important mechanisms of tumor suppressor genes are described below:

TP53 gene:

• The TP53 gene, also known as the “guardian of the genome,” encodes the p53 protein, which plays a central role in maintaining genomic stability and responding to cellular stress.
• The p53 protein regulates multiple processes, including cell cycle arrest, DNA repair, response to hypoxia, activation of oncogenes, and apoptosis.
• TP53 is the most frequently mutated tumor suppressor gene in human cancers, with mutations occurring in more than 50% of cancer cases.
• The p53 protein regulates the expression of several important proteins, including the cyclin-dependent kinase inhibitor p21, the pro-apoptotic protein BAX, and the anti-apoptotic protein BCL-2. It also promotes the release of cytochrome c from mitochondria, triggering apoptosis.
• Loss or malfunction of TP53 allows cells with damaged DNA to continue dividing and prevents the activation of programmed cell death, increasing the likelihood of cancer development.
• Inherited mutations in TP53 cause Li-Fraumeni syndrome, which is associated with a high risk of developing cancers such as breast cancer, sarcomas, leukemias, and other malignancies.

Retinoblastoma (RB1) gene:

• The RB1 gene is a critical tumor suppressor gene involved in regulating the cell cycle and is often described as the “governor of the cell cycle.”
• It encodes the retinoblastoma (RB) protein, which controls the transition from the G1 phase to the S phase of the cell cycle.
• Under normal conditions, the RB protein remains hypophosphorylated and binds to E2F transcription factors, preventing the expression of genes required for DNA replication and cell division.
• When cells receive appropriate growth signals, RB protein becomes phosphorylated, causing it to release E2F, which allows the cell cycle to progress and DNA replication to occur.
• In cancer cells, mutations or inactivation of the RB1 gene disrupt this regulatory mechanism, resulting in uncontrolled cell cycle progression and excessive cell proliferation.
• RB1 dysfunction is strongly associated with cancers such as Retinoblastoma and several other malignancies.

Functioning of Tumor Suppressor Genes:

Phosphatase and Tensin Homolog (PTEN) gene:

• The PTEN gene encodes a lipid phosphatase enzyme that plays an important role in regulating cell growth, survival, and proliferation.
• PTEN converts phosphatidylinositol (3,4,5)-trisphosphate (PIP3) into phosphatidylinositol (4,5)-bisphosphate (PIP2) by removing a phosphate group from PIP3 at the cell membrane.
• Through this activity, PTEN acts as a negative regulator of the phosphoinositide-3-kinase (PI3K)-AKT-mTOR signaling pathway, which normally promotes cell growth, division, metabolism, and survival.
• PTEN also contributes to the regulation of apoptosis (programmed cell death), cell migration, cell adhesion, and angiogenesis (formation of new blood vessels).
• When both copies of the PTEN gene are lost or inactivated, its tumor-suppressing function is disrupted, leading to excessive activation of growth-promoting pathways.
• PTEN dysfunction is frequently associated with the development of several cancers, including those involving the breast, prostate, endometrium, and other tissues.

CDH1 gene (E-cadherin):

• The CDH1 gene encodes E-cadherin (epithelial cadherin), a cell adhesion protein located on the membrane of epithelial cells.
• E-cadherin maintains tissue structure and organization by promoting strong cell-to-cell adhesion between neighboring epithelial cells.
• It plays an important role in contact inhibition, a process in which crowded cells stop dividing when they occupy limited space, preventing uncontrolled tissue growth.
• E-cadherin interacts with β-catenin, a key component of the WNT signaling pathway, and prevents its movement into the nucleus.
• By restricting β-catenin activity, E-cadherin prevents the activation of genes that promote cell proliferation and tumor formation.
• Mutations or loss of function in the CDH1 tumor suppressor gene weaken cell adhesion and disrupt normal growth control mechanisms.
• Inherited CDH1 mutations are strongly associated with Hereditary diffuse gastric cancer (HDGC), which increases the risk of diffuse gastric cancer and other malignancies.

Tumor Suppressor Gene	Gene Function	Major Cancer Associated
RB1	Regulates cell division, controls DNA replication, and promotes appropriate cell death (apoptosis).	Retinoblastoma
TP53	Controls cell cycle progression, promotes DNA repair, and activates apoptosis in damaged cells.	Li-Fraumeni syndrome (leukemia, sarcoma, brain tumors, and other cancers)
APC	Regulates cell division, cell migration, cell adhesion, DNA repair, and programmed cell death.	Colorectal cancer
BRCA1, BRCA2	Participate in repair of double-stranded DNA (dsDNA) breaks and regulation of the cell cycle.	Breast cancer and other hereditary cancers
WT1, WT2	Involved in transcriptional regulation and control of cell death.	Wilms’ tumor (childhood kidney cancer)
VHL	Regulates cell division, cellular differentiation, and apoptosis.	Kidney cancer (renal cell carcinoma)
NF1, NF2	Regulate RAS-mediated signal transduction, cell differentiation, and cell proliferation.	Nerve tumors, including brain and peripheral nerve tumors

References

• Chen, X., Zhang, T., Su, W., Dou, Z., Zhao, D., Jin, X., Lei, H., Wang, J., Xie, X., Cheng, B., Li, Q., Zhang, H., & Di, C. (2022). Mutant p53 in cancer: From molecular mechanism to therapeutic modulation. Cell Death & Disease, 13(11), 1–14. https://doi.org/10.1038/s41419-022-05408-1
• Joyce, C., Rayi, A., & Kasi, A. (2025). Tumor-suppressor genes. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK532243/
• MedlinePlus Genetics. (n.d.). PTEN gene. Retrieved June 8, 2025, from https://medlineplus.gov/genetics/gene/pten/
• National Human Genome Research Institute. (n.d.). Tumor suppressor gene. Retrieved June 7, 2025, from https://www.genome.gov/genetics-glossary/Tumor-Suppressor-Gene
• Cleveland Clinic. (n.d.). Tumor suppressor genes: Your protective cancer shield. Retrieved June 7, 2025, from https://my.clevelandclinic.org/health/body/24833-tumor-suppressor-genes
• Nature Education. (n.d.). Tumor suppressor (TS) genes and the two-hit hypothesis. Scitable. Retrieved June 7, 2025, from https://www.nature.com/scitable/topicpage/tumor-suppressor-ts-genes-and-the-two-887/